Erschienen in:
17.02.2023
Contemporary radiotherapy and radiosurgery techniques for refractory pituitary adenomas
verfasst von:
Roman O. Kowalchuk, Daniel M. Trifiletti, Paul D. Brown, Jason P. Sheehan
Erschienen in:
Pituitary
|
Ausgabe 3/2023
Einloggen, um Zugang zu erhalten
Abstract
The pituitary gland is a potential site for a range of pathologies, for which treatment can involve resection and/or ionizing radiation. Modern stereotactic radiosurgery (SRS) involves highly conformal radiation, allowing for the delivery of high doses to the tumor while simultaneously sparing nearby healthy structures. SRS has become a standard treatment option for residual or recurrent pituitary adenomas. It has been used for both functioning and nonfunctioning pituitary adenomas, with reported local tumor control over 90% and moderate rates of endocrine remission in functioning adenomas. We aim to briefly review the existing indictions and supporting literature for the use of SRS for refractory adenomas.